BNTX Overview
Upcoming Projects (BNTX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (BNTX)
-
Discussing the Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced Melanoma being developed by BioNTech
Ticker: BNTX
Executed On: Sep 11, 2024 at 06:30 PM EDT -
A Third Opinion: Discussing the current vaccine landscape and the potential of Pfizer's mRNA combination vaccine against influenza and COVID-19.
Tickers: PFE, BNTX
Executed On: Sep 11, 2024 at 02:30 PM EDT -
A Second Opinion: Discussing the current vaccine landscape and the potential of Pfizer's mRNA combination vaccine against influenza and COVID-19.
Tickers: PFE, BNTX
Executed On: Aug 23, 2024 at 10:00 AM EDT -
Discussing the current vaccine landscape and the potential of Pfizer's mRNA combination vaccine against influenza and COVID-19.
Tickers: PFE, BNTX
Executed On: Aug 22, 2024 at 11:00 AM EDT -
Discussing the results from the phase 1/2a study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of DB-1303 in patients with advanced/metastatic solid tumors
Ticker: BNTX
Executed On: Sep 18, 2023 at 11:30 AM EDT -
A second look at the preliminary Phase 1/2 data for first-in-class CAR-T program, BNT211 in treating testicular cancer
Ticker: BNTX
Executed On: Jul 13, 2022 at 06:15 PM EDT -
Discussing the preliminary Phase 1/2 data for first-in-class CAR-T program, BNT211, in treating testicular cancer
Ticker: BNTX
Executed On: Jun 17, 2022 at 07:45 AM EDT
Upcoming & Overdue Catalysts (BNTX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (BNTX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
